Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
A triple-action Formula for comprehensive respiratory relief
BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Vaccine helps protect against five common disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y)
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
Subscribe To Our Newsletter & Stay Updated
